Reference
Ritz, R., et al., Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines. Int. J. Oncol. 30, 659-667, (2007)
Yamazaki, T., et al., Excited-state properties of hypericin: electronic spectra and fluorescence decay kinetics. J. Phys. Chem. 97, 7870-7875, (1993)
Buytaert, E., et al., Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J. 20, 756-758, (2006)
Theodossiou, T.A., et al., Mitochondria are a primary target of hypericin phototoxicity: synergy of intracellular calcium mobilisation in cell killing. Int. J. Biochem. Cell Biol. 38, 1946-1956, (2006)
Kocanova, S., et al., Characterization of the interaction of hypericin with protein kinase C in U-87 MG human glioma cells. Photochem. Photobiol. 82, 720-728, (2006)
Blank, M., et al., Antimetastatic activity of the photodynamic agent hypericin in the dark. Int. J. Cancer 111, 596-603, (2004)
Miskovsky, P., Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. Curr. Drug Targets 3, 55-84, (2002)
Merck
Merck 13,4889
Beilstein
Beil. 8,IV,3761